Skip to content

Clinical trials

Recruiting Lung Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Recruiting Country / region: Belgium Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20171
20191
20224
20233
20244
20259
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Hoffmann-La Roche2
Medical University of Vienna2
University Hospital, Ghent2
Amgen1
AstraZeneca1
BioNTech SE1
Daiichi Sankyo1
DeuterOncology1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms26
Carcinoma, Non-Small-Cell Lung17
Neoplasms5
Breast Neoplasms4
Carcinoma3
Endocrine Gland Neoplasms3
Head and Neck Neoplasms3
Lung Diseases3
Ovarian Neoplasms3
Bronchial Neoplasms2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.